News

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other ...
A CRISPR treatment seems to have been effective for a baby’s devastating disease, but it is not clear whether such bespoke ...
A cell's primary cilia function like antennae. Operating like a 24/7 news outlet, these hairlike structures are present on the surface of all animal cells, where they receive signals or information ...
Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...
Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...
Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.
Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T ...
The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.
American depository receipts of Immutep rose after the company reported positive results from a trial of its combination treatment for non-small cell lung cancer. Immutep climbed 16% to $2.11 on ...